ENGINEERS FAROUK AHMED, GBENGA KOMOLAFE RESIGN, PRESIDENT TINUBU NOMINATES SUCCESSORS TO THE SENATE FOR APPROVAL. (PHOTO). #PRESS RELEASE.

Image
 STATEHOUSE PRESS RELEASE   ENGINEERS FAROUK AHMED, GBENGA KOMOLAFE RESIGN, PRESIDENT TINUBU NOMINATES SUCCESSORS TO THE SENATE FOR APPROVAL President Bola Ahmed Tinubu has asked the Senate to approve the nominations of two new chief executives for the Nigerian Midstream and Downstream Petroleum Regulatory Authority (NMDPRA) and the Nigerian Upstream Petroleum Regulatory Commission (NUPRC).   The requests followed the resignation of Engineer Farouk Ahmed of the NMDPRA and Gbenga Komolafe of the NUPRC. Both officials were appointed in 2021 by former President Buhari to lead the two regulatory agencies created by the Petroleum Industry Act (PIA).   To fill these positions, President Tinubu has written to the Senate, requesting expedited confirmation of Oritsemeyiwa Amanorisewo Eyesan as CEO of NUPRC and Engineer Saidu Aliyu Mohammed as CEO of NMDPRA.   The two nominees are seasoned professionals in the oil and gas industry.   Eyesan, a graduate of Economics f...

WORLD'S SECOND MALARIA VACCINE LAUNCHED IN IVORY COAST, LATEST MILESTONE IN FIGHT AGAINST THE DISEASE. (PHOTO).


 World's second malaria vaccine launched in Ivory Coast, latest milestone in fight against the disease



The world's second vaccine against malaria was launched on Monday as the Ivory Coast began a routine vaccine program using shots developed by the University of Oxford and the Serum Institute of India.


The introduction of the World Health Organization (WHO)-approved R21 vaccine comes six months after the first malaria vaccine, called RTS,S and developed by British drugmaker GSK, began being administered in a routine program in Cameroon.


Some 15 African countries plan to introduce one of the two malaria vaccines this year with support from the Gavi global vaccine alliance.


Ivory Coast has received a total of 656,600 doses of the Oxford and Serum shot, which will initially vaccinate 250,000 children aged between 0 and 23 months across the West African country. The vaccine has also been approved by Ghana, Nigeria, Burkina Faso and the Central African Republic.


The rollout of a second vaccine is the latest milestone in the global fight against malaria and should help address a problem that emerged well before either of the two shots was launched: demand for them is likely to far outstrip supply for several years.


Experts say having safe and effective malaria vaccines is important to meet demand. The shot is meant to work alongside existing tools - such as bed nets - to combat malaria, which in Africa kills nearly half a million children under the age of five each year.


The Serum Institute of India, which manufactures the vaccine, has produced 25 million doses for the initial rollout of the shot and "is committed to scaling up to 100 million doses annually", the company said on Monday about the launch in the Ivory Coast.


Serum said it is offering the vaccine for less than $4 per dose, in keeping with its aim to deliver low-cost vaccines at scale.


Results from a large trial in February showed the vaccine prevented around three-quarters of symptomatic malaria cases in young children the first year after they got the shots.


Experts told Reuters at that time that comparing the two malaria vaccines head-to-head was difficult because of the many variables involved in the trials, but overall their performance was similar - a conclusion endorsed by WHO.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.